Antithrombotic and antiplatelet activities of Soshiho-tang extract

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Lee, Jung Jin ^a   Kim, Taesoo ^a   Cho, Won Kyung ^a   Ma, Jin Yeul ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Antiplatelet activity; Antithrombotic activity; Serotonin secretion; Soshiho tang; TXB2 formation

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CYCLOOXYGENASE 1; FERRIC CHLORIDE; PLANT EXTRACT; SEROTONIN; SOSHIHO TANG EXTRACT; THROMBIN; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CAROTID ARTERY INJURY; CONTROLLED STUDY; EXPERIMENTAL RABBIT; GINGER; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; RAT; SCUTELLARIA BAICALENSIS; SEROTONIN RELEASE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TRADITIONAL MEDICINE; TREATMENT DURATION;

ANIMALS; ANTITHROMBINS; BLOOD COAGULATION; DRUGS, CHINESE HERBAL; HUMANS; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; THROMBOSIS; THROMBOXANE B2;

EID: 84879068488     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-137     Document Type: Article

References (26)

1. Steinhubl SR, Moliterno DJ. The role of the platelet in the pathogenesis of atherothrombosis. Am J Cardiovasc Drugs 2005, 5(6):399-408. 10.2165/00129784-200505060-00007, 16259528.
2. Lange RA, Hillis LD. Antiplatelet therapy for ischemic heart disease. N Engl J Med 2004, 350(3):277-280. 10.1056/NEJMe038191, 14724308.
3. Serebruany VL, Malinin AI, Eisert RM, Sane DC. Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials. Am J Hematol 2004, 75(1):40-47. 10.1002/ajh.10451, 14695631.
4. Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004, 104(10):3190-3197. 10.1182/blood-2004-03-0935, 15280200.
5. Furie B, Furie BC. The molecular basis of blood coagulation. Cell 1988, 53(4):505-518.
6. Mann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost 1999, 82(2):165-174.
7. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002, 22(9):1381-1389. 10.1161/01.ATV.0000031340.68494.34, 12231555.
8. Majid A, Delanty N, Kantor J. Antiplatelet agents for secondary prevention of ischemic stroke. Ann Pharmacother 2001, 35(10):1241-1247.
9. Brass LF. Thrombin and platelet activation. Chest 2003, 124(3 Suppl):18S-25S.
10. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002, 8(11):1227-1234. 10.1038/nm1102-1227, 12411949.
11. Gibbins JM. Platelet adhesion signalling and the regulation of thrombus formation. J Cell Sci 2004, 117(Pt 16):3415-3425.
12. Jonnakuty C, Gragnoli C. What do we know about serotonin?. J Cell Physiol 2008, 217(2):301-306. 10.1002/jcp.21533, 18651566.
13. Daibo A, Yoshida Y, Kitazawa S, Kosaka Y, Bando T, Sudo M. A case of pneumonitis and hepatic injury caused by a herbal drug (sho-saiko-to). Nihon Kyobu Shikkan Gakkai Zasshi 1992, 30(8):1583-1588.
14. Kawasaki A, Mizushima Y, Kunitani H, Kitagawa M, Kobayashi M. A useful diagnostic method for drug-induced pneumonitis: a case report. Am J Chin Med 1994, 22(3-4):329-336.
15. Huang XX, Yamashiki M, Nakatani K, Nobori T, Mase A. Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a Gel Doc system. J Clin Lab Anal 2001, 15(4):199-209. 10.1002/jcla.1028, 11436203.
16. Chen MH, Chen JC, Tsai CC, Wang WC, Chang DC, Tu DG, Hsieh HY. The role of TGF-beta 1 and cytokines in the modulation of liver fibrosis by Sho-saiko-to in rat's bile duct ligated model. J Ethnopharmacol 2005, 97(1):7-13. 10.1016/j.jep.2004.09.040, 15652268.
17. Zhang Y, Wang X, Xu Z, Liu Z, Ni Q, Chu X, Qiu M, Zhao A, Jia W. Protective effect of flavonoids from Scutellaria baicalensis Georgi on cerebral ischemia injury. J Ethnopharmacol 2006, 108(3):355-360. 10.1016/j.jep.2006.05.022, 16829002.
18. Liao YR, Leu YL, Chan YY, Kuo PC, Wu TS. Anti-platelet aggregation and vasorelaxing effects of the constituents of the rhizomes of Zingiber officinale. Molecules 2012, 17(8):8928-8937.
19. Nie H, Meng LZ, Zhang H, Zhang JY, Yin Z, Huang XS. Analysis of anti-platelet aggregation components of Rhizoma zingiberis using chicken thrombocyte extract and high performance liquid chromatography. Chin Med J (Engl) 2008, 121(13):1226-1229.
20. Lee JJ, Jin YR, Yu JY, Munkhtsetseg T, Park ES, Lim Y, Kim TJ, Pyo MY, Hong JT, Yoo HS, et al. Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug. Atherosclerosis 2009, 206(2):375-382. 10.1016/j.atherosclerosis.2009.02.034, 19345949.
21. Born GV, Cross MJ. The aggregation of blood platelets. J Physiol 1963, 168:178-195. 1359417, 14056485.
22. Lee JJ, Yu JY, Lee JH, Zhang WY, Kim TJ, Myung CS, Yun YP. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase. Arch Pharm Res 2010, 33(3):387-394. 10.1007/s12272-010-0307-1, 20361303.
23. Nishihira K, Yamashita A, Tanaka N, Kawamoto R, Imamura T, Yamamoto R, Eto T, Asada Y. Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery. J Thromb Haemost 2006, 4(1):247-255. 10.1111/j.1538-7836.2005.01702.x, 16409475.
24. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, et al. Guidelines on myocardial revascularization. Eur Heart J 2010, 31(20):2501-2555.
25. Jackson SP, Nesbitt WS, Kulkarni S. Signaling events underlying thrombus formation. J Thromb Haemost 2003, 1:1602-1612. 10.1046/j.1538-7836.2003.00267.x, 12871297.
26. Farndale RW, Sixma JJ, Barnes MJ, De Groot PG. The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2004, 2:561-573. 10.1111/j.1538-7836.2004.00665.x, 15102010.